An important limitation of this study was the need to validate the impact of the identified profiles and gene expressions (USP7, USP15, UBE2T, and UBE2O) through both protein expression and Next-Generation Sequencing and mutation analysis, as these could affect the correct functioning of these genes in MDS patients. This evidence concerns the gene UBE2T and myelodysplastic syndrome.